Beyond animal testing: The rise of organoids in toxicology research
Drug Discovery World
MARCH 20, 2024
Around 30% of drugs show adverse reactions during human clinical trials despite promising pre-clinical studies. They can be developed from both normal and diseased tissue and remain stable when expanded ex vivo in the lab, offering a distinct advantage for testing off-target and on-target toxicities within the same patient sample.
59 
Let's personalize your content